Treatment with OA also reduced the indices of inflammation and autoimmunity in colon tissues, (i.e., increased TNFα, IL-1β, IL-23, IL-17A, and KC; and reduced IL-13, IL-33, and IL-25). The gene discussed is IL33; the disease is Autoimmunity.